tiprankstipranks
Trending News
More News >
Inspecs Group Plc (GB:SPEC)
LSE:SPEC
Advertisement

Inspecs Group Plc (SPEC) AI Stock Analysis

Compare
9 Followers

Top Page

GB

Inspecs Group Plc

(LSE:SPEC)

Rating:52Neutral
Price Target:
48.00p
▲(3.23%Upside)
The overall score is primarily influenced by financial performance challenges, including declining revenues and negative profitability. Technical indicators show neutral market conditions, while valuation metrics suggest potential overvaluation. Positive corporate events provide some optimism regarding governance and leadership stability.

Inspecs Group Plc (SPEC) vs. iShares MSCI United Kingdom ETF (EWC)

Inspecs Group Plc Business Overview & Revenue Model

Company DescriptionInspecs Group Plc (SPEC) is a global eyewear company that designs, manufactures, and distributes a comprehensive range of spectacle frames and lenses. Operating within the optical and fashion eyewear sectors, the company caters to a diverse customer base, including major retail chains, independent opticians, and branded eyewear companies. Inspecs offers an extensive portfolio of licensed and owned brands, appealing to a wide array of style preferences and consumer demographics.
How the Company Makes MoneyInspecs Group Plc generates revenue primarily through the sale of eyewear products, including spectacle frames and lenses. The company operates a vertically integrated model, overseeing the entire production process from design to distribution. This allows Inspecs to maintain control over quality and costs while providing competitive pricing. Key revenue streams include wholesale distribution to optical retailers and direct sales to consumers through owned retail outlets. Additionally, Inspecs benefits from strategic partnerships and licensing agreements with renowned fashion and lifestyle brands, enabling them to expand their brand portfolio and attract a broader consumer base. The company's global distribution network and manufacturing facilities in Asia and Europe further enhance its ability to efficiently serve international markets, contributing to its overall earnings.

Inspecs Group Plc Financial Statement Overview

Summary
Inspecs Group Plc is facing profitability challenges, with declining revenues and negative net income. The balance sheet reflects manageable leverage but shows a declining equity base. Cash flow generation needs improvement, as indicated by reduced free cash flow. Overall, the company needs to address its profitability and cash flow issues to enhance financial stability.
Income Statement
45
Neutral
Inspecs Group Plc experienced a decline in revenue over the past year, with a negative revenue growth rate. The gross profit margin stands at approximately 52.2%, indicating decent production efficiency. However, the company is facing challenges in profitability, as reflected by a negative net profit margin and a declining EBIT margin. The EBITDA margin of 7.9% suggests some operational efficiency, but overall profitability remains under pressure.
Balance Sheet
58
Neutral
The balance sheet shows a moderate debt-to-equity ratio of 0.63, suggesting manageable leverage levels. However, the return on equity is negative, indicating a lack of profitability with respect to shareholder investments. The equity ratio of 44.8% reflects a reasonable proportion of equity financing, but the declining equity position over recent years raises concerns about financial stability.
Cash Flow
50
Neutral
The company's free cash flow has decreased year-over-year, reflecting challenges in cash generation. The operating cash flow to net income ratio is positive, indicating that the company generates cash from operations despite reporting losses. However, the decline in free cash flow growth rate highlights the need for improved cash flow management.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue198.26M203.29M248.58M246.47M47.41M
Gross Profit103.45M103.55M122.29M115.77M20.52M
EBITDA15.75M17.27M12.06M6.05M
Net Income-4.61M-997.00K-7.82M-5.43M-8.91M
Balance Sheet
Total Assets220.25M221.91M292.68M326.36M310.45M
Cash, Cash Equivalents and Short-Term Investments23.96M20.07M26.80M29.76M32.67M
Total Debt62.47M62.12M84.42M84.92M79.86M
Total Liabilities121.56M118.39M162.59M181.13M164.64M
Stockholders Equity98.69M103.52M130.09M145.22M145.82M
Cash Flow
Free Cash Flow4.28M6.92M842.00K12.37M-3.37M
Operating Cash Flow7.20M12.66M5.08M20.02M-748.00K
Investing Cash Flow-2.52M-6.18M-4.19M-15.66M-104.40M
Financing Cash Flow-426.00K-8.84M-4.40M1.70M128.71M

Inspecs Group Plc Technical Analysis

Technical Analysis Sentiment
Negative
Last Price46.50
Price Trends
50DMA
46.61
Negative
100DMA
46.10
Positive
200DMA
47.73
Negative
Market Momentum
MACD
0.31
Positive
RSI
38.37
Neutral
STOCH
20.04
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SPEC, the sentiment is Negative. The current price of 46.5 is below the 20-day moving average (MA) of 48.45, below the 50-day MA of 46.61, and below the 200-day MA of 47.73, indicating a bearish trend. The MACD of 0.31 indicates Positive momentum. The RSI at 38.37 is Neutral, neither overbought nor oversold. The STOCH value of 20.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:SPEC.

Inspecs Group Plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
82
Outperform
£198.00M32.1519.61%4.07%10.32%1.25%
71
Outperform
£5.32B35.8211.12%2.10%3.94%41.63%
GBAMS
67
Neutral
£441.19M61.782.93%1.27%40.66%-55.09%
57
Neutral
£4.74B6.48-61.44%5.43%33.02%6.17%
52
Neutral
£47.28M-4.56%-2.48%-362.24%
40
Underperform
£43.02M-63.28%1557.07%24.70%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:SPEC
Inspecs Group Plc
46.50
-8.50
-15.45%
GB:CTEC
ConvaTec
260.80
23.07
9.70%
GB:SBTX
SkinBioTherapeutics
16.62
6.87
70.46%
GB:TSTL
Tristel
415.00
-19.26
-4.44%
GB:AMS
Advanced Medical Solutions
204.50
-23.18
-10.18%

Inspecs Group Plc Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Inspecs Group Plc Grants CEO Share Options to Align Leadership Interests
Positive
Jun 4, 2025

Inspecs Group Plc has announced the grant of options to acquire 400,000 Ordinary Shares to its CEO, Richard Peck, under the Inspecs Long Term Incentive Plan 2020. This move is part of the company’s strategy to incentivize leadership and align executive interests with shareholder value, potentially impacting the company’s operational focus and market positioning.

Executive/Board ChangesShareholder MeetingsBusiness Operations and Strategy
Inspecs Group Faces Tariff Challenges, Seeks New Leadership
Neutral
Jun 3, 2025

Inspecs Group plc announced at its Annual General Meeting that US tariffs are affecting sales, but European demand is improving and projects in North America are progressing well. The company is conducting a strategic review of its lens business, Norville, and is searching for a new Independent Non-Executive Chair and Chief Financial Officer. Despite challenges, Inspecs is focused on operational efficiency and cost-saving measures, expecting flat revenue for 2025 compared to 2024. Robin Totterman will step down as Chair, ensuring a smooth transition for the new leadership.

Executive/Board ChangesBusiness Operations and Strategy
Inspecs Group Announces Board Changes and Governance Update
Positive
May 29, 2025

Inspecs Group plc announced updates on its Board composition and the withdrawal of a requisition notice for a general meeting. The company is in the process of appointing a new Independent Non-Executive Chair to replace Robin Totterman, who will step down as Executive Chair at the upcoming AGM. Christopher Hancock will serve as Interim Chair until a new appointment is made. Additionally, the search for a new Chief Financial Officer is progressing well. Downing LLP has withdrawn its requisition notice for a general meeting, indicating a stabilization in the company’s governance. These developments suggest a focus on ensuring leadership stability and continuity, which could positively impact Inspecs’ operational performance and stakeholder confidence.

Business Operations and Strategy
Inspecs Group PLC Announces Change in Major Holdings
Neutral
May 23, 2025

Inspecs Group PLC has announced a change in its major holdings, with Luke Johnson acquiring a significant increase in voting rights, now holding 5.86% of the total voting rights. This acquisition highlights a shift in shareholder dynamics, potentially impacting the company’s strategic decisions and influencing its market positioning.

Executive/Board ChangesShareholder Meetings
Inspecs Group Rejects Board Changes Proposed by Downing LLP
Neutral
May 14, 2025

Inspecs Group plc has received a requisition notice from Downing LLP to convene a general meeting to vote on the removal of Robin Totterman as a director and the appointment of Rocco Benetton as Executive Chairman. The Board unanimously rejects these proposals, emphasizing the importance of an independent chair and the ongoing search for a new Non-Executive Chair. The Board advises shareholders to await further announcements and highlights Robin Totterman’s continued value to the company.

Business Operations and StrategyRegulatory Filings and Compliance
Inspecs Group PLC Announces Change in Major Holdings
Neutral
May 8, 2025

Inspecs Group PLC has announced a change in its major holdings, as Luke Johnson has acquired or disposed of voting rights, resulting in a 3.79582189% shareholding. This adjustment in voting rights may influence the company’s governance and decision-making processes, potentially impacting its strategic direction and stakeholder interests.

Shareholder MeetingsFinancial Disclosures
INSPECS Group Announces AGM and Annual Report Release
Neutral
May 6, 2025

INSPECS Group plc has announced the posting of its Annual Report and Accounts along with the Notice of its Annual General Meeting (AGM) to shareholders, with the AGM scheduled for June 3, 2025, in Bath, Somerset. This announcement reflects the company’s ongoing commitment to transparency and stakeholder engagement, as it continues to expand its global footprint and enhance its product offerings in the competitive eyewear industry.

Executive/Board ChangesShareholder Meetings
INSPECS Announces Board Update as Director Departs
Neutral
Apr 16, 2025

INSPECS Group plc announced that Hugo Adams, a Non-Executive Director, will not seek re-election at the upcoming Annual General Meeting due to his new role as CEO of Kelpi, a sustainable materials company. The board expressed gratitude for his contributions and plans to provide further updates on board composition in the future.

Financial Disclosures
INSPECS Group Confirms Unchanged Audited Full-Year Results for 2024
Positive
Apr 15, 2025

INSPECS Group plc has released its audited full-year results for the year ending December 31, 2024, confirming that there are no changes from the previously announced unaudited results. This announcement underscores the company’s stable financial performance and transparency, which may reassure stakeholders and investors about its market position and operational consistency.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 11, 2025